Please login to the form below

Not currently logged in
Email:
Password:

UK

This page shows the latest UK news and features for those working in and with pharma, biotech and healthcare.

Finch Therapeutics bags $53m for microbiome therapies

Finch Therapeutics bags $53m for microbiome therapies

Last June, Roche’s biotech division Genentech signed a $534m deal with UK biotech Microbiotica, to access its precision metagenomics microbiome platform to analyse patient samples from clinical trials of its

Latest news

  • Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate

    In the US, the oral liquid product costs $32, 500 for a year's worth of treatment. The company hasn't confirmed its UK list price yet, but NICE has already ... It then anticipates launches expected in France, Germany and UK by the end of the year, with

  • NICE’s long-serving chief exec Sir Andrew Dillon to step down NICE’s long-serving chief exec Sir Andrew Dillon to step down

    Cutbacks in public sector spending in the UK in recent years have seen the organisation forced to streamline its operations, while at the same time taking on responsibility for reviews of ... Mike Thompson, chief executive of the UK industry association

  • Roche’s Hemlibra scores broader NHS funding Roche’s Hemlibra scores broader NHS funding

    There are an estimated 5, 930 people registered with haemophilia A in the UK, which means Hemlibra will be available to around a third of all patients. ... prophylactic medicine that can be administered subcutaneously and maintains a sustained

  • NICE’s fast-track catapults Skyrizi into market NICE’s fast-track catapults Skyrizi into market

    The fast-track approval is great news for Boehringer and AbbVie – the latter has seen its UK revenues from Humira (adalimumab) plummet since late 2018. ... Dr Alice Butler, UK medical director, AbbVie confirmed last month that Skyrizi’s NICE

  • UK no longer measles-free as vaccination rates fall dramatically UK no longer measles-free as vaccination rates fall dramatically

    PM Boris Johnson calls for urgent action. The UK has lost its measles-free status just three years after the World Health Organization (WHO) declared that the country had eliminated the ... The falling rates of childhood vaccinations is not a problem

More from news
Approximately 315 fully matching, plus 3,216 partially matching documents found.

Latest Intelligence

  • AI is transforming pharma R&D – now it can transform pharma marketing AI is transforming pharma R&D – now it can transform pharma marketing

    Early successes. In 2018 Teva created Braltusbot, a chatbot for HCPs on their UK Braltus website. ... Kim Innes, General Manager, Teva UK and Ireland said: “The experience for a worried HCP must be seamless.

  • The evolution of real-world studies The evolution of real-world studies

    UK strength. The level of trust placed in RWE depends largely on the source of the data. ... AstraZeneca is putting its confidence in UK infrastructure to the test in a pragmatic trial designed to compare the effectiveness of diabetes drug Forxiga to the

  • The fight for affordable insulin The fight for affordable insulin

    Dialogue with pharma? No thanks. As with the UK’s Cystic Fibrosis Buyers’ Club advocates, T1International doesn’t see dialogue with pharma as being worthwhile – after years of frustration and debates

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Diarmaid McDonald is lead organiser of Just Treatment, a UK-based patient activist group which is challenging the government to take whatever steps necessary to ensure access to new medicines at ... Just Treatment is also urging the UK government to

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    The work was centred around an awareness campaign on meningococcal meningitis, and the need for vaccination, targeting 15-24-year olds – the second highest at-risk group in the UK.

More from intelligence
Approximately 27 fully matching, plus 412 partially matching documents found.

Latest appointments

  • Senior leadership moves announced at Publicis Health Senior leadership moves announced at Publicis Health

    Spurgeon has held a senior role at Langland UK, a Publicis Health company, for the past decade. ... In her new role as Group Managing Director, Victoria will also take on responsibility for leading Langland in the UK”.

  • F-star hires ex-BMS immuno-oncology leader

    New CMO to oversee development of lead candidate. UK biotech F-star has appointed Louis Kayitalire, MD, as its new Chief Medical Officer (CMO), wooing him from a senior role in ... F-star says this newly created management position will be crucial

  • Synergy Studio continues to grow Synergy Studio continues to grow

    Ailsa Stewart, UK managing director at Synergy said: “Having an in-house studio function gives numerous benefits to our clients, allowing us to communicate data and messages in the most effective

  • Health comms agency emotive hires new cell and gene therapy leader Health comms agency emotive hires new cell and gene therapy leader

    Dr Germano Ferrari. His most recent role was as a programme manager at the UK’s Cell and Gene Therapy Catapult where he helped develop commercialisation pathways for several pre-clinical

  • McCann Health bolsters European leadership team McCann Health bolsters European leadership team

    The newly-created role is one that will see Bartlett take responsibility for its UK and France-based offerings, as well as overseeing McCann Health’s consulting arm.

More from appointments
Approximately 15 fully matching, plus 589 partially matching documents found.

Latest from PMHub

  • Porphyria Awareness Week – Round Up

    Porphyria Awareness Week has given the team at emotive an opportunity to show our support for those touched by this debilitating Rare Disease as well as our enthusiasm for working in this field. Porphyria is a rare condition that is thought to

  • emotive supports Rare Disease Day 2019

    To find out more about rare diseases, visit  Rare Disease UK. You can also find out about the great work of Medics 4 Rare Disease – including our partnership – on their  website

  • emotive appoints a Mental Health First Aider

    To round off stress awareness month, emotive is pleased to announce the appointment of our first Mental Health First aider, Kate Wagstaff, Senior Account Executive. As a global healthcare communications agency, emotive recognises that although our

  • Day in the life of an emotive Art Director

    Nairn, our Art Director, holds a degree in Graphic Design from Duncan of Jordanstone College of Art &Design, University of Dundee. He joined emotive in 2013 as a Junior Designer and has been a part of the team for over six years. What are you

  • Learning about Rare Genetic Disorders on Undiagnosed Children’s Day

    Currently around 50% of children undergoing genetic testing in the UK will not get a confirmed diagnosis. ... The UK has become the first country to take Whole Genome Sequencing, a cutting-edge biotechnology, into mainstream healthcare.

More from PMHub
Approximately 33 fully matching, plus 1,028 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics